Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
Go back to Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device| (NYSE: OGN) | Delayed: 13.56 +0.04 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.52 | 52 Week High | $8.00 | |||
| Open | $13.51 | 52 Week Low | $8.00 | |||
| Day High | $13.58 | P/E | N/A | |||
| Day Low | $13.51 | EPS | $0.00 | |||
| Volume | 6,563,596 | |||||
